Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03177187
Title Combination Study of AZD5069 and Enzalutamide. (ACE)
Recruitment Active, not recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Institute of Cancer Research, United Kingdom
Indications

prostate adenocarcinoma

Therapies

AZD5069 + Enzalutamide

Age Groups: senior | adult
Covered Countries

Facility Status City State Zip Country Details
Bellinzona Hospital Bellinzona Switzerland Details
Belfast City Hospital Belfast UK BT9 7AB United Kingdom Details
The Royal Marsden Hospital Foundation Trust Sutton UK SM2 5PT United Kingdom Details
University Hospital Southampton Southampton United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field